HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Netherlands’ Norgine Sets Up OTC Business And Targets Acquisitions

Executive Summary

By establishing a dedicated consumer healthcare subsidiary, Norgine is hoping it can grow its $200m-plus Movicol laxative brand and take advantage of M&A opportunities in the OTC market.

You may also be interested in...



People On The Move: Appointments At GSK, Reckitt And Norgine

A round-up of the latest health and wellness appointments: GSK makes addition to senior management teams in Europe; Reckitt appoints general counsel; and Norgine announces CEO change.

Norgine Drives Role As Specialty Partner For Europe

The mid-sized pharmaceutical company Norgine aims to grow its specialty business in Europe through targeted business development activities, while at the same time separating out its consumer healthcare activities into a new subsidiary.

Nestlé Spies APAC Expansion Potential With Deal for New Zealand's Better Health

Nestlé Health Science continues to expand its dietary supplements offering in 2022 penning a deal for New Zealand's The Better Health Company and its GO Healthy brand. The company says the deal will strengthen its presence not just in New Zealand but across the wider APAC region in markets such as Australia and China.

Topics

Latest News
UsernamePublicRestriction

Register

RS150770

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel